Skip to main content
SpringerLink
Log in

Mitral Regurgitation: Diagnosis and Timing of Intervention

  • Chapter
  • First Online:
Percutaneous Treatment of Left Side Cardiac Valves

  • 1055 Accesses

Abstract

The clinical manifestations of mitral regurgitation (MR) are conditioned by the magnitude and rapidity of onset and the ability of the chambers of the heart to adapt from a hemodynamic and neuroendocrine perspective. Patients with MR are often asymptomatic despite a severe degree of valve regurgitation. The major symptom is dyspnea, at first on exertion and then at rest, accompanied by peripheral edemas, marked asthenia, and palpitations. The most serious clinical manifestation is acute pulmonary edema [1].

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Log in via an institution
Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 69.99
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD 89.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info
Hardcover Book
USD 119.99
Price excludes VAT (USA)
  • Durable hardcover edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

References

  1. Woolley K, Stark P. Pulmonary parenchymal manifestations of mitral valve disease. Radiographics. 1999;19(4):965–72.

    Google Scholar 

  2. Rahimtoola SH, Dell’Italia LJ. Mitral valve disease. In: Fuster V, Alexander RW, O’Rourke RA, et al., editors. Hurst’s the heart. 11th ed. New York: McGraw-Hill; 2004. p. 1669–95.

    Google Scholar 

  3. American College of Cardiology, American Heart Association Task Force on Practice Guidelines (Writing Committee to revise the 1998 guidelines for the management of patients with valvular heart disease), Society of Cardiovascular Anesthesiologists, Bonow RO, Carabello BA, Chatterjee K, et al. ACC/AHA 2006 guidelines for the management of patients with valvular heart disease: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (writing Committee to Revise the 1998 guidelines for the management of patients with valvular heart disease) developed in collaboration with the Society of Cardiovascular Anesthesiologists endorsed by the Society for Cardiovascular Angiography and Interventions and the Society of Thoracic Surgeons. J Am Coll Cardiol. 2006;48:1–148.

    Article  Google Scholar 

  4. Vahanian A, Baumgartner H, Bax J, et al. Task Force on the Management of Valvular Heart Disease of the European Society of Cardiology ESC Committee for Practice Guidelines. Guidelines on the management of valvular heart disease: the Task Force on the Management of Valvular Heart Disease of the European Society of Cardiology. Eur Heart J. 2007;28:230–68.

    PubMed  Google Scholar 

  5. Bonow RO, Carabello BA, Chatterjee K, et al. American College of Cardiology/American Heart Association Task Force on Practice Guidelines. 2008 focused update incorporated into the ACC/AHA 2006 guidelines for the management of patients with valvular heart disease: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Writing Committee to revise the 1998 guidelines for the management of patients with valvular heart disease): endorsed by the Society of Cardiovascular Anesthesiologists, Society for Cardiovascular Angiography and Interventions, and Society of Thoracic Surgeons. Circulation. 2008;118:523–661.

    Article  Google Scholar 

  6. Zoghbi WA, Eriquez-Sarano M, Foster E, et al. Recommendations for evaluation of the severity of native valvular regurgitation with two-dimensional and doppler echocardiography. J Am Soc Echocardiogr. 2003;16:777–802.

    Article  PubMed  Google Scholar 

  7. Bargiggia GS, Tronconi L, Sahn DJ, et al. A new method for quantitation of mitral regurgitation based on color flow Doppler imaging of flow convergence proximal to regurgitant orifice. Circulation. 1991;84:1481–9.

    Article  CAS  PubMed  Google Scholar 

  8. Simpson IA, Shiota T, Gharib M, et al. Current status of flow convergence for clinical applications: is it a leaning tower of “PISA”? J Am Coll Cardiol. 1996;27:504–9.

    Article  CAS  PubMed  Google Scholar 

  9. Baumgartner H, Schima H, Kuhn P. Value and limitations of proximal jet dimensions for the quantitation of valvular regurgitation: an in vitro study using Doppler flow imaging. J Am Soc Echocardiogr. 1991;4:57–66.

    Article  CAS  PubMed  Google Scholar 

  10. Sahn DJ. Instrumentation and physical factors related to visualization of stenotic and regurgitant jets by Doppler color flow mapping. J Am Coll Cardiol. 1988;12:1354–65.

    Article  CAS  PubMed  Google Scholar 

  11. Pu M, Griffin BP, Vandervoort PM, et al. The value of assessing pulmonary venous flow velocity for predicting severity of mitral regurgitation: a quantitative assessment integrating left ventricular function. J Am Soc Echocardiogr. 1999;12:736–43.

    Article  CAS  PubMed  Google Scholar 

  12. Thomas L, Foster E, Schiller NB. Peak mitral in flow velocity predicts mitral regurgi tation severity. J Am Coll Cardiol. 1998;31:174–9.

    Article  CAS  PubMed  Google Scholar 

  13. Lancellotti P, Moura L, Pierard LA, et al. European Association of Echocardiography recommendations for the assessment of valvular regurgitation. Part 2: mitral and tricuspid regurgitation (native valve disease). Eur J Echocardiogr. 2010;11:307–32.

    Article  PubMed  Google Scholar 

  14. Nishimura RA, Otto CM, Bonow RO, Carabello BA, Erwin JP 3rd, Guyton RA, O’Gara PT, Ruiz CE, Skubas NJ, Sorajja P, Sundt TM 3rd, Thomas JD, Anderson JL, Halperin JL, Albert NM, Bozkurt B, Brindis RG, Creager MA, Curtis LH, DeMets D, Guyton RA, Hochman JS, Kovacs RJ, Ohman EM, Pressler SJ, Sellke FW, Shen WK, Stevenson WG, Yancy CW, American College of Cardiology, American College of Cardiology/American Heart Association, American Heart Association. 2014 AHA/ACC guideline for the management of patients with valvular heart disease: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines. J Thorac Cardiovasc Surg. 2014;148(1):e1–32. doi:10.1016/j.jtcvs.2014.05.014. Epub 9 May 2014.

    Article  PubMed  Google Scholar 

  15. Lancellotti P, Gérard P, Piérard LA. Long term outcome of patients with heart failure and dynamic functional mitral regurgitation. Eur Heart J. 2005;26:1528–32.

    Article  PubMed  Google Scholar 

  16. Enriquez-Sarano M, Basmadjian AJ, Rossi A, et al. Progression of mitral regurgitation: a prospective Doppler echocardiographic study. J Am Coll Cardiol. 1999;34:1137–44.

    Article  CAS  PubMed  Google Scholar 

  17. Lancellotti P, Lebrun F, Piérard LA. Determinants of exercise-induced changes in mitral regurgitation in patients with coronary artery disease and left ventricular dysfunction. J Am Coll Cardiol. 2003;42:1921–8.

    Article  PubMed  Google Scholar 

  18. Shiota T. Role of modern 3D echocardiography in valvular heart disease. Korean J Intern Med. 2014;29(6):685–702. doi:10.3904/kjim.2014.29.6.685. Epub 31 Oct 2014. Review.

    Article  PubMed  PubMed Central  Google Scholar 

  19. Sugeng L, Shernan SK, Salgo IS, et al. Live 3-dimensional transesophageal echocardiography initial experience using the fully-sampled matrix array probe. J Am Coll Cardiol. 2008;52:446–9.

    Article  PubMed  Google Scholar 

  20. Biaggi P, Gruner C, Jedrzkiewicz S, et al. Assessment of mitral valve prolapse by 3D TEE. J Am Coll Cardiol Img. 2011;4:94–7.

    Article  Google Scholar 

  21. Quader N, Rigolin VH. Two and three dimensional echocardiography for pre-operative assessment of mitral valve regurgitation. Cardiovasc Ultrasound. 2014;12:42. doi:10.1186/1476-7120-12-42.

    Article  PubMed  PubMed Central  Google Scholar 

  22. Altiok E, Hamada S, van Hall S, et al. Comparison of direct planimetry of mitral valve regurgitation orifice area by three-dimensional transesophageal echocardiography to effective regurgitant orifice area obtained by proximal flow convergence method and vena contracta area determined by color Doppler echocardiography. Am J Cardiol. 2011;107:452–8.

    Article  PubMed  Google Scholar 

  23. Yosefy C, Levine RA, Solis J, Vaturi M, Handschumacher MD, Hung J. Proximal flow convergence region as assessed by real-time 3-dimensional echocardiography: challenging the hemispheric assumption. J Am Soc Echocardiogr. 2007;20:389–96.

    Article  PubMed  Google Scholar 

  24. Matsumura Y, Saracino G, Sugioka K, et al. Determination of regurgitant orifice area with the use of a new three-dimensional flow convergence geometric assumption in functional mitral regurgitation. J Am Soc Echocardiogr. 2008;21:1251–6.

    Article  PubMed  Google Scholar 

  25. Hopmeyer J, He S, Thorvig KM, et al. Estimation of mitral regurgitation with a hemielliptic curve-fitting algorithm: in vitro experiments with native mitral valves. J Am Soc Echocardiogr. 1998;11:322–31.

    Article  CAS  PubMed  Google Scholar 

  26. Morris M, Araoz P. Advanced imaging of mitral valve disease. US Cardiol. 2011;8:24–9.

    Google Scholar 

  27. Zeng X, Levine RA, Hua L, Morris EL, Kang Y, Flaherty M, Morgan NV, Hung J. Diagnostic value of vena contracta area in the quantification of mitral regurgitation severity by color Doppler 3D echocardiography. Circ Cardiovasc Imaging. 2011;4(5):506–13. doi:10.1161/CIRCIMAGING.110.961649. Epub 5 Jul 2011.

    Article  PubMed  PubMed Central  Google Scholar 

  28. Glockner JF, Johnston DL, McGee KP. Evaluation of cardiac valvular disease with MR imaging: qualitative and quantitative techniques. Radiographics. 2003;23:9.

    Article  Google Scholar 

  29. Schnyder PA, Sarraj AM, Duvoisin BE, et al. Pulmonary edema associated with mitral regurgitation: prevalence of predominant involvement of the right upper lobe. AJR Am J Roentgenol. 1993;161:33–6.

    Article  CAS  PubMed  Google Scholar 

  30. Hayek E, Gring CN, Griffin BP. Mitral valve prolapse. Lancet. 2005;365:507–18.

    Article  PubMed  Google Scholar 

  31. D’Ancona G, Mamone G, Marrone G, et al. Ischemic mitral valve regurgitation: the new challenge for magnetic resonance imaging. Eur J Cardiothorac Surg. 2007;32:475–80.

    Article  PubMed  Google Scholar 

  32. Rubinshtein R, Glockner JF, Ommen SR, et al. Characteristics and clinical significance of late gadolinium enhancement by contrast-enhanced magnetic resonance imaging in patients with hypertrophic cardiomyopathy. Circ Heart Fail. 2010;3:51–8.

    Article  PubMed  Google Scholar 

  33. Guo YK, Yang ZG, Ning G, et al. Isolated mitral regurgitation: quantitative assessment with 64-section multidetector CT—comparison with MR imaging and echocardiography. Radiology. 2009;252:369–76.

    Article  PubMed  Google Scholar 

  34. Gelfand EV, Hughes S, Hauser TH, et al. Severity of mitral and aortic regurgitation as assessed by cardiovascular magnetic resonance: optimizing correlation with Doppler echocardiography. J Cardiovasc Magn Reson. 2006;8:503–7.

    Article  PubMed  Google Scholar 

  35. Grossman W, Baim DS. Grossman’s cardiac catheterization, angiography and intervention. 7th ed. Baltimore: Lippincott Williams and Wilkins; 2006.

    Google Scholar 

  36. Braunwald E, Awe W. The syndrome of severe mitral regurgitation with normal left atrial pressure. Circulation. 1963;27:29–35.

    Article  CAS  PubMed  Google Scholar 

  37. Chikwe J, Adams DH. State of the art: degenerative mitral valve disease. Heart Lung Circ. 2009;18:319–29.

    Article  PubMed  Google Scholar 

  38. Delahaye JP, Gare JP, Viguier E, et al. Natural history of severe mitral regurgitation. Eur Heart J. 1991;12:5–9.

    Article  PubMed  Google Scholar 

  39. Enriquez-Sarano M, Freeman WK, Tribouilloy CM, et al. Functional anatomy of mitral regurgitation: accuracy and outcome implications of TEE. J Am Coll Cardiol. 1999;34:1129–36.

    Article  CAS  PubMed  Google Scholar 

  40. Thamilarasan M, Griffin B. Choosing the most appropriate valve operation and prosthesis. Cleve Clin J Med. 2002;69:668–703.

    Article  Google Scholar 

  41. Lee EM, Shapiro LM, Wells FC. Superiority of mitral valve repair in surgery for degenerative mitral regurgitation. Eur Heart J. 1997;18:655–63.

    Article  CAS  PubMed  Google Scholar 

  42. Enriquez-Sarano M, Schaff HV, Orszulak TA, et al. Valve repair improves the outcome of surgery for mitral regurgitation. A multivariate analysis. Circulation. 1995;91:1022–228.

    Article  CAS  PubMed  Google Scholar 

  43. Trichon BH, Felker GM, Shaw LK, et al. Relation of frequency and severity of mitral regurgitation to survival among patients with left ventricular systolic dysfunction and heart failure. Am J Cardiol. 2003;91:538–43.

    Article  PubMed  Google Scholar 

  44. Ling LH, Enriquez-Sarano M, Seward JB, et al. Clinical outcome of mitral regurgitation due to flail leaflet. N Engl J Med. 1996;335:1417–23.

    Article  CAS  PubMed  Google Scholar 

  45. Tribouilloy CM, Enriquez-Sarano M, Schaff HV, et al. Impact of preoperative symptoms on survival after surgical correction of organic mitral regurgitation: rationale for optimizing surgical implications. Circulation. 1999;99:400–5.

    Article  CAS  PubMed  Google Scholar 

  46. Crawford MH, Souchek J, Oprian CA, et al. Determinants of survival and left ventricular performance after mitral valve replacement. Department of Veterans Affairs Cooperative Study on Valvular Heart Disease. Circulation. 1990;81:1173–81.

    Article  CAS  PubMed  Google Scholar 

  47. Enriquez-Sarano M, Tajik AJ, Schaff HV, et al. Echocardiographic prediction of left ventricular function after correction of mitral regurgitation: results and clinical implications. J Am Coll Cardiol. 1994;24:1536–43.

    Article  CAS  PubMed  Google Scholar 

  48. Sherrid MV, Clark RD, Cohn K. Echocardiographic analysis of left atrial size before and after operation in mitral valve disease. Am J Cardiol. 1979;43:171–8.

    Article  CAS  PubMed  Google Scholar 

  49. Nashef SA, Roques F, Michel P, et al. European system for cardiac operative risk evaluation (EuroSCORE). Eur J Cardiothorac Surg. 1999;16:9–13.

    Article  CAS  PubMed  Google Scholar 

  50. Enriquez-Sarano M, Rossi A, Seward JB, et al. Determinants of pulmonary hypertension in left ventricular dysfunction. J Am Coll Cardiol. 1997;29:153–9.

    Article  CAS  PubMed  Google Scholar 

  51. Carabello BA. The current therapy for mitral regurgitation. J Am Coll Cardiol. 2008;52:319–26.

    Article  PubMed  Google Scholar 

  52. DiSalvo T, Acker MA, Dec GW, et al. Mitral valve surgery in advanced heart failure. J Am Coll Cardiol. 2010;55:271–82.

    Article  Google Scholar 

  53. Bishay ES, McCarthy PM, Cosgrove DM, et al. Mitral valve surgery in patients with severe left ventricular dysfunction. Eur J Cardiothorac Surg. 2000;17:213–21.

    Article  CAS  PubMed  Google Scholar 

  54. Wu AH, Aaronson KD, Bolling SF, et al. Impact of mitral valve annuloplasty on mortality risk in patients with mitral regurgitation and left ventricular systolic dysfunction. J Am Coll Cardiol. 2005;45:381–7.

    Article  PubMed  Google Scholar 

  55. Gaasch WH, Meyer TE. Left ventricular response to mitral regurgitation: implications for management. Circulation. 2008;118:2298–303.

    Article  PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Division of Cardiology, Ferrarotto Hospital, University of Catania, Catania, Italy

    Marta Chiarandà, Sarah Mangiafico & Salvatore Scandura

Authors
  1. Marta Chiarandà
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Sarah Mangiafico
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Salvatore Scandura
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Salvatore Scandura .

Editor information

Editors and Affiliations

  1. Ferrarotto Hospital, University of Catania, Catania, Italy

    Corrado Tamburino

  2. Ferrarotto Hospital, University of Catania, Catania, Italy

    Marco Barbanti

  3. Ferrarotto Hospital, University of Catania, Catania, Italy

    Davide Capodanno

Rights and permissions

Reprints and permissions

Copyright information

© 2018 Springer International Publishing AG

About this chapter

Cite this chapter

Chiarandà, M., Mangiafico, S., Scandura, S. (2018). Mitral Regurgitation: Diagnosis and Timing of Intervention. In: Tamburino, C., Barbanti, M., Capodanno, D. (eds) Percutaneous Treatment of Left Side Cardiac Valves. Springer, Cham. https://doi.org/10.1007/978-3-319-59620-4_4

Download citation

  • DOI: https://doi.org/10.1007/978-3-319-59620-4_4

  • Published:

  • Publisher Name: Springer, Cham

  • Print ISBN: 978-3-319-59619-8

  • Online ISBN: 978-3-319-59620-4

  • eBook Packages: MedicineMedicine (R0)

Publish with us

Policies and ethics

Search

Navigation